search
Back to results

Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)

Primary Purpose

Acute Pain, Soft Tissue Injury

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Diclofenac Sodium
Matching Placebo Patch
Sponsored by
Cerimon Pharmaceuticals
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Pain focused on measuring diclofenac, acute pain, topical, patch, Acute Pain due to Mild to Moderate Soft Tissue Injury

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male and female subjects 18-75 years of age
  • Sustained recent, painful unilateral mild to moderate soft tissue injury (between the mid-bicep to wrist or mid-thigh to ankle)
  • Meet baseline pain criterion

Exclusion Criteria:

  • Open wound or infection at site of injury
  • Evidence of severe injury, including fracture or nerve injury
  • Use of oral NSAIDs or opioids within 12-24 hours of injury
  • Presence or history of peptic ulcers or GI bleeding
  • A history of intolerance to NSAIDs, acetaminophen, adhesives
  • Positive pregnancy test
  • Positive drug screen

Sites / Locations

  • PPD

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Diclofenac Sodium Patch

Topical Placebo Patch

Arm Description

Outcomes

Primary Outcome Measures

Change in average pain during daily activity at Day 7

Secondary Outcome Measures

Change in average pain during daily activity at Day 14

Full Information

First Posted
June 29, 2009
Last Updated
August 12, 2010
Sponsor
Cerimon Pharmaceuticals
Collaborators
PPD
search

1. Study Identification

Unique Protocol Identification Number
NCT00931866
Brief Title
Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)
Official Title
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Diclofenac Sodium Patch for the Topical Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries
Study Type
Interventional

2. Study Status

Record Verification Date
August 2010
Overall Recruitment Status
Completed
Study Start Date
April 2009 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
December 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Cerimon Pharmaceuticals
Collaborators
PPD

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium topical patch in reducing mild to moderate soft tissue injuries when applied to the painful area.
Detailed Description
This randomized, double-blind, placebo-controlled, parallel group study will be conducted in patients with mild to moderate soft tissue injuries. Eligible patients will be randomized (in a 1:1 ratio) to receive double-blind treatment with either the diclofenac topical patch or a matching placebo patch to be applied once daily for 14 days. Patients will return to the clinic for assessments on Day 3, Day 7 and Day 14; a follow-up assessment will be conducted on Day 21. Patients will complete an electronic diary in which assessments including pain intensity and pain relief will be recorded twice daily. Functional disability and global impression of change will be recorded in the diary at study visits, ratings of the quality of sleep will be recorded in the diary each morning, and the use of study treatment and rescue medication will be recorded in the diary each day.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Pain, Soft Tissue Injury
Keywords
diclofenac, acute pain, topical, patch, Acute Pain due to Mild to Moderate Soft Tissue Injury

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
407 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diclofenac Sodium Patch
Arm Type
Experimental
Arm Title
Topical Placebo Patch
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Diclofenac Sodium
Intervention Description
Topical diclofenac patch applied once daily to area of pain
Intervention Type
Drug
Intervention Name(s)
Matching Placebo Patch
Intervention Description
Matching placebo patch, containing identical constituents to the active comparator except for diclofenac sodium; applied once daily
Primary Outcome Measure Information:
Title
Change in average pain during daily activity at Day 7
Time Frame
Day 7
Secondary Outcome Measure Information:
Title
Change in average pain during daily activity at Day 14
Time Frame
Day 14

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male and female subjects 18-75 years of age Sustained recent, painful unilateral mild to moderate soft tissue injury (between the mid-bicep to wrist or mid-thigh to ankle) Meet baseline pain criterion Exclusion Criteria: Open wound or infection at site of injury Evidence of severe injury, including fracture or nerve injury Use of oral NSAIDs or opioids within 12-24 hours of injury Presence or history of peptic ulcers or GI bleeding A history of intolerance to NSAIDs, acetaminophen, adhesives Positive pregnancy test Positive drug screen
Facility Information:
Facility Name
PPD
City
Austin
State/Province
Texas
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)

We'll reach out to this number within 24 hrs